Home » Topics » BioWorld Science

BioWorld Science
RSS

UCn2 gene transfer improves diabetes-related left-ventricular dysfunction in mice

Sep. 3, 2019

Eicosis' soluble epoxide hydrolase inhibitor EC-5026 to enter the clinic

Sep. 3, 2019

Lower affinity means lower affinity, but higher persistence, for CAR T cells

Sep. 3, 2019

Alcohol consumption is deceased with FGFR1 inhibition in rodents

Sep. 3, 2019

First preclinical data presented on miR-132 inhibitor CDR132L in heart failure model

Sep. 3, 2019

Panitumumab-IRDye800 in phase II for metastatic lymph node identification in HNSCC

Sep. 3, 2019

POU3F3 disruptions linked to neurodevelopmental disorder

Sep. 3, 2019

Checkpoint blockade protects from homeostatic inhibition and amplifies antitumor T-cell responses

Sep. 3, 2019

Preclinical characterization of the novel covalent Inhibitor of CDK7, SY-1365

Sep. 3, 2019

Phase II data reported for P2Y12 inhibitor selatogrel in CAD patients

Sep. 2, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...